Jul 07, 2020
Aesculap Implant Systems Announces New Positive Third-Party Clinical Guidelines that May Introduce Access for More than 8.5 Million Commercially Insured Americans to the activL® Artificial Disc
Jun 18, 2020
Aesculap Celebrates Five-Year Anniversary of the FDA Approval of the activL® Artificial Disc: Five Years and Five Milestones
Feb 21, 2020
Scott Hacker, MD Treats his Tenth Patient in Pivotal Phase 3 Clinical Trial of NOVOCART® 3D in Patients with Articular Cartilage Defects of the Knee
Jan 28, 2019
New Study Finds Plasmapore®XP Surface Enhancement Demonstrates Enhanced Osseointegrative Properties
Sep 25, 2018
Maintenance of motion at L5/S1 does matter.
Jul 03, 2018
UnitedHealthcare's New Positive Medical Policy in Favor of Lumbar Total Disc Replacement Reconfirms the Procedure's Long-Term Effectiveness and Value for the Treatment of Degenerative Disc Disease
Jun 04, 2018
Aesculap Implant Systems Announces U.S. Military's TRICARE Now Covers Lumbar Total Disc Replacement
Apr 12, 2018
Lumbar Artificial Disc Replacement with the activL® Artificial Disc Found to be More Effective at Delaying the Progression of Adjacent-Level Disease, a Costly Outcome which Spinal Fusion has been Found to Accelerate
Nov 09, 2017
NASS 2017 Best Paper Sessions Provide Significant Insights into the Long-Term Results of activL® Artificial Disc
Sep 28, 2017
Journal of Comparative Effectiveness Research Publishes Pivotal Level 1 Evidence Comparing activL® Artificial Disc to ProDisc-L, Fusion and Conservative Care